FDMT   $5.86  -7.86% Market Closed

4D Molecular Therapeutics Inc
Total Cash 541.95M
totalCashPerShare 10.428
EBITDA -126.75M
Total Debt 13.66M
quickRatio 27.931
currentRatio 28.482
Total Revenue 20.22M
debtToEquity 2.321
Revenue/Share 0.426
ROA -0.16864
ROE -0.24059999
grossProfits
freeCashflow -52.98M
operatingCashflow -85.15M
earningsGrowth
revenueGrowth -0.979
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins -8491.2
profitMargins 0.0
enterpriseValue -92.27M
forwardPE -2.5379941
floatShares 26.40M
sharesOutstanding 51.97M
sharesShort 9.49M
sharesShortPriorMonth 9.52M
dateShortInterest
sharesPercentSharesOut 0.18%
heldPercentInsiders 0.03%
heldPercentInstitutions 1.15%
Short Ratio help_outline 8.01%
shortPercentOfFloat 0.19%
impliedSharesOutstanding
bookValue 11.333
Price To Book help_outline 0.74
earningsQuarterlyGrowth
netIncomeToCommon -109.89M
trailingEps -2.24%
forwardEps -3.29%
enterpriseToEbitda 0.73
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.7 3Q 2024
institutionsCount 217
lastUpdated Nov. 7, 2024, 3:30 a.m.